Riskpilot← Back to searchSign inGet full accessAthlin Medical AB
ABActiveOrg 5592555071Muningatan 19Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
SEK 3,3M
-15% vs 2024
EBITDA margin
56.5%
-17% vs 2024
Equity ratio
71.9%
Financial strength
Net profit 2025
SEK 1,4M
-18% vs 2024
| Revenue | SEK 3,3M | -15% |
| EBITDA | SEK 1,9M | -17% |
| Net profit | SEK 1,4M | -18% |
| Total assets | SEK 9,4M | +20% |
| Equity | SEK 6,8M | +14% |
| Employees | 1 | — |
Legal name
Athlin Medical AB
Org number
5592555071
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 maj 2020
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva hälso- och sjukvård, samt utbildning och konsultverksamhet inom dessa områden samt därmed förenlig verksamhet.
Address
Muningatan 19
Email
athlin@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 252 | 2 617 | 2 875 | 3 852 | 3 277 |
| Staff expenses | — | −595 | −734 | −1 404 | −1 138 |
| EBITDA | 3 144 | 1 909 | 1 961 | 2 228 | 1 852 |
| Depreciation & amort. | −0 | — | — | — | −5 |
| EBIT | 3 144 | 1 909 | 1 961 | 2 228 | 1 847 |
| Net financials | −1 | −3 | −10 | 4 | −2 |
| Profit before tax | 2 393 | 1 409 | 1 455 | 2 232 | 1 841 |
| Tax | −523 | −307 | −307 | −471 | −391 |
| Net profit | 1 870 | 1 103 | 1 148 | 1 761 | 1 449 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 626 | 5 458 | 6 027 | 7 869 | 9 435 |
| Equity | 1 920 | 3 023 | 4 171 | 5 932 | 6 781 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 955 | 1 188 | 113 | 194 | 907 |
| Total debt | 955 | 1 188 | 113 | 194 | 907 |
EBITDA margin
56.5%
This company
15.8%
Market median
+258% vs market
20212025
Equity ratio
71.9%
This company
38.2%
Market median
+88% vs market
20212025
Return on equity
21.4%
This company
18.4%
Market median
+16% vs market
20212025
Net profit margin
44.2%
This company
8.1%
Market median
+446% vs market
20212025
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20212025
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Athlin Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Arthur Joakim Athlin | Chief Executive Officer | 0 companies |
| Anna Maria Lilly Öhman | Board of Directors | 0 companies |
| Lars Wolger Svedin | Chairman | 0 companies |
| Siv Inger Backman | Board of Directors | 0 companies |
| Erik Arthur Mattias Athlin | Deputy Board Member | 0 companies |